(1 - 8 from 16
)
Medicine may be key to cloning's future
medicalxpress.com
Cloning would be an efficient way to create them, said Yann Echelard, GTC vice president of corporate and technology development. There are ways to do this without cloning, but it's a more predictable process, he said. Now that the FDA has said it's safe to consume the milk and meat from cloned animals, ...
rEVO Biologics begins Phase III trial of preeclampsia drug ATrynwww.clinicaltrialsarena.com › news › newsrevo-biologi...
www.clinicaltrialsarena.com
rEVO Biologics president Yann Echelard said the company is happy to start the PRESERVE-1 clinical trial for the management of early-onset ...
sorted by relevance / date